Position in TCRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$1
-$1,979 QoQ
Shares Held
1
-99.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TCRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,427,808,560 across 402 Biotechnology names. TCRX ranks #389 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
682,807 | $304,900,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
184,691 | $142,699,654 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
263,375 | $87,142,884 | |
| 4 | MRNA |
Moderna, Inc.
|
1,480,034 | $75,185,727 | |
| 5 | FOLD |
AMICUS THERAPEUTICS, INC.
|
4,226,882 | $61,120,713 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
746,483 | $55,433,827 | |
| 7 | INCY |
Incyte Corp
|
489,649 | $46,085,763 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,536,110 | $42,550,246 |
All Filings in TCRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1 | 1 | Shares | Defined | 2026-05-11 | |
| 2025-09-30 | $1,980 | 1,088 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $17,069 | 11,772 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $38,840 | 28,146 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $122,337 | 40,243 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $138,409 | 27,793 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $49,409 | 8,446 | Shares | Defined | 2024-08-12 | |
| 2024-03-31 | $928,352 | 116,921 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $426,540 | 73,163 | Shares | Defined | 2024-02-09 | |
| No filing history on record for this holder in this stock. | ||||||